论文部分内容阅读
目的:探讨消化道溃疡的临床治疗的疗效。方法:从我院2014年1月-2015年1月期间收治的消化道溃疡患者中随机抽取68例作为本次研究的对象,分为两组,给予对照组法莫替丁治疗,研究组则在对照组基础上联合奥美拉唑治疗,分析两组临床治疗效果。结果:治疗后,研究组临床总有效率94.12%、Hp转阴率85.29%,明显高于对照组临床总有效率79.41%、Hp转阴率58.82%,组间比较有统计学的意义(<0.05);且研究组溃疡复发率2.94%,明显低于对照组溃疡复发率17.65%,组间比较差异显著,存在统计学方面的意义(P<0.05)。结论:法莫替丁联合奥美拉唑治疗消化道溃疡的临床效果较为显著,值得在临床上进一步推广应用。
Objective: To investigate the efficacy of clinical treatment of peptic ulcer. Methods: A total of 68 patients with peptic ulcer admitted to our hospital from January 2014 to January 2015 were randomly divided into two groups: control group, famotidine group, and study group On the basis of the control group combined with omeprazole treatment, analysis of two groups of clinical treatment. Results After treatment, the total clinical effective rate was 94.12% and the Hp negative conversion rate was 85.29% in the study group, which was significantly higher than that in the control group (79.41%) and Hp negative conversion rate (58.82%) (< 0.05). The ulcer recurrence rate was 2.94% in the study group, which was significantly lower than that in the control group (17.65%). There was significant difference between the two groups (P <0.05). Conclusion: Famotidine plus omeprazole in the treatment of peptic ulcer clinical effect is more significant, it is worth further clinical application.